Champions Oncology, Inc. (CSBR): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2019-04-30, while the company's latest annual report covers the year ended 2026-04-30. Its later filings do not report this line under the concept TickerFacts maps.
$3.24M
As of 2019-04-30
$4.36M
As of 2026-07-31
+7.8%
3-year compound annual growth
-11.3%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2019-04-30 | $3.24M | +278.2% | 2019-07-29, Balance as of period end |
| 2018-04-30 | $856.0K | -74.0% | 2019-07-29, Balance as of period end |
| 2017-04-30 | $3.29M | +27.5% | 2018-07-30, Balance as of period end |
| 2016-04-30 | $2.58M | -72.4% | 2017-07-28, Balance as of period end |
| 2015-04-30 | $9.36M | +58.8% | 2016-07-29, Balance as of period end |
| 2014-04-30 | $5.89M | -38.4% | 2015-07-29, Balance as of period end |
| 2013-04-30 | $9.56M | +101.1% | 2014-07-28, Balance as of period end |
| 2012-04-30 | $4.75M | -54.5% | 2013-07-26, Balance as of period end |
| 2011-04-30 | $10.46M | n/a | 2012-07-18, Balance as of period end |